These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 8502518
21. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?]. Sefer S, Kes P, Raić B, Heinrich B, Degoricija V, Szavits-Nossan J. Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844 [Abstract] [Full Text] [Related]
23. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P. Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778 [Abstract] [Full Text] [Related]
24. Blood coagulopathy in dogs with shock induced by injection of heartworm extract. Kitoh K, Watoh K, Kitagawa H, Sasaki Y. Am J Vet Res; 1994 Nov; 55(11):1542-7. PubMed ID: 7879977 [Abstract] [Full Text] [Related]
25. Activated partial thromboplastin time-protamine dose relation in the presence and absence of heparin. Inagaki M, Goto K, Katayama H, Benson KT, Goto H, Arakawa K. J Cardiothorac Anesth; 1989 Dec; 3(6):734-6. PubMed ID: 2521031 [Abstract] [Full Text] [Related]
26. Standardization of coagulation tests. Opartkiattikul N. Southeast Asian J Trop Med Public Health; 1999 Dec; 30 Suppl 3():79-85. PubMed ID: 10926265 [Abstract] [Full Text] [Related]
27. A comparison of the quantitative action of protamine and heparin on blood coagulation. Significance in clinical and laboratory usage. Perkash A. Am J Clin Pathol; 1980 May; 73(5):676-81. PubMed ID: 7377134 [Abstract] [Full Text] [Related]
28. An assessment of the utility of unselected coagulation screening in general hospital practice. McHugh J, Holt C, O'Keeffe D. Blood Coagul Fibrinolysis; 2011 Mar; 22(2):106-9. PubMed ID: 21245744 [Abstract] [Full Text] [Related]
29. Removal of heparin and protamine from plasma. Thompson AR, Counts RB. J Lab Clin Med; 1976 Dec; 88(6):922-9. PubMed ID: 993645 [Abstract] [Full Text] [Related]
30. Comparison of coagulation test results for blood samples obtained by means of direct venipuncture and through a jugular vein catheter in clinically normal dogs. Millis DL, Hawkins E, Jager M, Boyle CR. J Am Vet Med Assoc; 1995 Nov 15; 207(10):1311-4. PubMed ID: 7591925 [Abstract] [Full Text] [Related]
31. Activated coagulation time in monitoring heparinized dogs. Green RA. Am J Vet Res; 1980 Nov 15; 41(11):1793-7. PubMed ID: 7212408 [Abstract] [Full Text] [Related]
32. Reliability of an intravenous intermittent access port (saline lock) for obtaining blood samples for coagulation studies. Arrants J, Willis ME, Stevens B, Gripkey L, Herman JA, Hernandez-Brooks L, Eaker JE. Am J Crit Care; 1999 Sep 15; 8(5):344-8. PubMed ID: 10467472 [Abstract] [Full Text] [Related]
33. Aprotinin and heparin monitoring during cardiopulmonary bypass. Hunt BJ, Segal H, Yacoub M. Circulation; 1992 Nov 15; 86(5 Suppl):II410-2. PubMed ID: 1385011 [Abstract] [Full Text] [Related]
34. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin. Francis JL, Howard C. Blood Coagul Fibrinolysis; 1993 Feb 15; 4(1):35-40. PubMed ID: 7681330 [Abstract] [Full Text] [Related]
35. Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. Cushing DJ, Cooper WD, Cohen ML, McVoy JR, Sobel M, Harris RB. Eur J Pharmacol; 2010 Jun 10; 635(1-3):165-70. PubMed ID: 20307530 [Abstract] [Full Text] [Related]
36. A comparison of coagulation study results between heparinized peripherally inserted central catheters and venipunctures. Humphries L, Baldwin KM, Clark KL, Tenuta V, Brumley K. Clin Nurse Spec; 2012 Jun 10; 26(6):310-6. PubMed ID: 23059715 [Abstract] [Full Text] [Related]
37. [Quantitative estimation of preanalytical variables which may influence the determinations of prothrombin time (PT) and activated partial thromboplastin time (APTT)]. Isa K, Yamauchi MS, Nago TT, Yamane N. Rinsho Byori; 2010 Oct 10; 58(10):979-85. PubMed ID: 21077287 [Abstract] [Full Text] [Related]
38. Time to hemostasis after traction removal of tunneled cuffed central venous catheters. Stecker MS, Johnson MS, Ying J, McLennan G, Agarwal DM, Namyslowski J, Ahmad I, Shah H, Butty S, Casciani T. J Vasc Interv Radiol; 2007 Oct 10; 18(10):1232-9; quiz 1240. PubMed ID: 17911513 [Abstract] [Full Text] [Related]
39. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass. Tao W, Deyo DJ, Brunston RL, Vertrees RA, Grochoske TL, Zwischenberger JB. ASAIO J; 1997 Oct 10; 43(5):M825-30. PubMed ID: 9360162 [Abstract] [Full Text] [Related]
40. The effects of supraceliac aortic clamping on the anticoagulant effects of heparin. Money SR, Ballinger BA, Crockett DE, Chatman DM, Lohmann TP. Am J Surg; 1996 Aug 10; 172(2):155-7. PubMed ID: 8795520 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]